BLACK WEEKSFlacoane −15% · kituri −10% · restul −5%cu codulLivrare gratuită în Germania de la 200 €

Această pagină a fost tradusă automat și poate conține erori. Sunteți vorbitor nativ? Ne bucurăm să primim feedbackul și corecturile dumneavoastră.Trimiteți feedback

The Peptide Desk The Peptide Desk
Insulin Glargin U300 (Toujeo), fotografie produs
Medication

Insulin Glargin U300 (Toujeo)

Medication

  • Livrare din Germania

Comandă

Preț unitar - Livrare gratuită în Germania de la 200 € în timpul Black Weeks
  • DHL cu urmărire
  • Ambalare discretă

4.6 din 5 pe Trustpilot73 recenzii

Pe scurt

Insulin Glargin U300 (Toujeo) în cifre

Valorile principale din lexiconul nostru.

Articolul complet din lexicon
Class
Long-acting basal insulinanalogue
Use
Subcutaneousonce daily, pen only
Sizes
1.5ml/450iu1 size in the shop

Pentru Insulin Glargin U300 (Toujeo) nu există încă o analiză de laborator. Votați pentru elToate analizele de laborator

Informații

Totul despre Insulin Glargin U300 (Toujeo)

FAQ

Întrebări frecvente

Surse pentru fiecare răspuns: articolul din lexicon

Mai aveți o întrebare?

Scrieți-ne, echipa noastră vă ajută.

How does U300 differ from U100?

Only the concentration: 300 instead of 100 units per millilitre, the same compound. The smaller depot releases it more evenly. In a 36-hour clamp level and effect ran flatter over 24 hours and tight glucose control lasted a median of about 30 hours, around 5 hours longer than with U100.

Why is a regular insulin syringe dangerous?

Regular insulin syringes are calibrated for U-100. With U300 solution the same mark holds three times the amount and you cannot see it. In the FDA drug database the 300 units/ml version is only listed as a prefilled injector with 1.5 or 3 ml, not as a vial.

Is Insulin Glargine U300 approved?

Yes. Drugs@FDA lists the 300 units/ml version since 25 February 2015. ChEMBL lists the compound insulin glargine with first approval in 2000. Everything here is the state of research, not a recommendation.

What did the EDITION trials show?

Same glucose control, less hypoglycaemia at night. In EDITION 1 (807 participants) 36 instead of 46 percent had night-time hypoglycaemia. The pooled analysis of EDITION 1 to 3 with 2,496 people found 31 percent less night-time and 14 percent less around-the-clock hypoglycaemia. Severe episodes stayed rare (2.3 versus 2.6 percent).

Does U300 need more units?

Slightly. In EDITION 2 U300 needed about 10 percent more units than U100 for the same reduction of the long-term value. Weight gain was lower with U300.

Does the time of day matter?

In EDITION 4 with 549 people with type 1 diabetes the result was the same in the morning and in the evening, including hypoglycaemia. Fewer night-time episodes than with U100 were only seen there in the first eight weeks, weight gain was lower.

Produse asemănătoare

Produse similare